Rapt Therapeutics, Inc. (RAPT)
58.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 04, 16:00
Rapt Therapeutics Total Liabilities (Quarterly) : 13.76M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Penumbra, Inc. | 398.92M |
| Amicus Therapeutics, Inc. | 675.63M |
| Disc Medicine, Inc. | 67.05M |
| Amylyx Pharmaceuticals, Inc. | 28.82M |
| Johnson & Johnson | 117.67B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.74M |
| Shareholders Equity (Quarterly) | 151.98M |
| Debt to Equity Ratio | 0.0171 |
| Current Ratio | 12.04 |
| Net Debt Paydown Yield | 0.15% |